Each of our programs is geared towards a specific purpose that will help fill the gaps in research. All programs include all stakeholders, including patient families, clinicians, and researchers. Our programs run in parallel that will eventually meet a common goal, treatments.
To understand the basics around SYNGAP1, read our updated paper of SYNGAP1 and our new treatment guidelines. The NORD paper was the first comprehensive paper published on SYNGAP1 by the National Organization of Rare Disorders through a collaboration between by our teams at Texas Children’s Hospital, Scripps Research (Jupiter, FL, Campus), Johns Hopkins Medicine, Kennedy Krieger Institute and Bridge the Gap – Syngap Education and Research Foundation.